207 related articles for article (PubMed ID: 32584631)
1. Performance Status in Cancer: Not Broken, But Time for an Upgrade?
Scott JM; Stene G; Edvardsen E; Jones LW
J Clin Oncol; 2020 Sep; 38(25):2824-2829. PubMed ID: 32584631
[No Abstract] [Full Text] [Related]
2. Measure Me, Don't Judge Me: Patients as Objective Contributors to Performance Status Measurement.
Salmi L; Warner JL
JCO Clin Cancer Inform; 2018 Dec; 2():1-4. PubMed ID: 30652569
[No Abstract] [Full Text] [Related]
3. Interconversion of three measures of performance status: an empirical analysis.
Ma C; Bandukwala S; Burman D; Bryson J; Seccareccia D; Banerjee S; Myers J; Rodin G; Dudgeon D; Zimmermann C
Eur J Cancer; 2010 Dec; 46(18):3175-83. PubMed ID: 20674334
[TBL] [Abstract][Full Text] [Related]
4. Karnofsky performance status and assessment of global health status.
Murri R; Scoppettuolo G; Damiano F; Ammassari A; Fantoni M; Antinori A
J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Nov; 13(3):294-5. PubMed ID: 8898676
[No Abstract] [Full Text] [Related]
5. The Palliative Performance Scale #125.
Wilner LS; Arnold RM
J Palliat Med; 2006 Aug; 9(4):994. PubMed ID: 16910815
[No Abstract] [Full Text] [Related]
6. Neoplastic meningitis-related prognostic significance of the Karnofsky performance status.
Chamberlain MC; Johnston SK; Glantz MJ
Arch Neurol; 2009 Jan; 66(1):74-8. PubMed ID: 19139302
[TBL] [Abstract][Full Text] [Related]
7. Use of the Palliative Performance Scale in survival prediction for terminally ill patients in Western Newfoundland, Canada.
Lau F; Bell H; Dean M; Downing M; Lesperance M
J Palliat Care; 2008; 24(4):282-4. PubMed ID: 19227023
[No Abstract] [Full Text] [Related]
8. JAMA Oncology Patient Page. Performance Status in Patients With Cancer.
West HJ; Jin JO
JAMA Oncol; 2015 Oct; 1(7):998. PubMed ID: 26335750
[No Abstract] [Full Text] [Related]
9. Karnofsky Performance Scale (KPS) or Physical Performance Test (PPT)? That is the question.
Terret C; Albrand G; Moncenix G; Droz JP
Crit Rev Oncol Hematol; 2011 Feb; 77(2):142-7. PubMed ID: 20185330
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of performance status assessed by patients themselves, nurses, and oncologists in advanced non-small cell lung cancer.
Ando M; Ando Y; Hasegawa Y; Shimokata K; Minami H; Wakai K; Ohno Y; Sakai S
Br J Cancer; 2001 Nov; 85(11):1634-9. PubMed ID: 11742480
[TBL] [Abstract][Full Text] [Related]
11. The Functionality Assessment Flowchart (FAF): a new simple and reliable method to measure performance status with a high percentage of agreement between observers.
Paiva CE; Siquelli FA; Santos HA; Costa MM; Massaro DR; Lacerda DC; Nunes JS; de Pádua Souza C; Paiva BS
BMC Cancer; 2015 Jul; 15():501. PubMed ID: 26142726
[TBL] [Abstract][Full Text] [Related]
12. Assessment of Karnofsky (KPS) and WHO (WHO-PS) performance scores in brain tumour patients: the role of clinician bias.
Frappaz D; Bonneville-Levard A; Ricard D; Carrie S; Schiffler C; Xuan KH; Weller M
Support Care Cancer; 2021 Apr; 29(4):1883-1891. PubMed ID: 32789684
[TBL] [Abstract][Full Text] [Related]
13. Karnofsky Performance Scale validity and reliability of Turkish palliative cancer patients.
Yıldız Çeltek N; Süren M; Demir O; Okan İ
Turk J Med Sci; 2019 Jun; 49(3):894-898. PubMed ID: 31192546
[TBL] [Abstract][Full Text] [Related]
14. Should patient-rated performance status affect treatment decisions in advanced lung cancer?
Dajczman E; Kasymjanova G; Kreisman H; Swinton N; Pepe C; Small D
J Thorac Oncol; 2008 Oct; 3(10):1133-6. PubMed ID: 18827609
[TBL] [Abstract][Full Text] [Related]
15. Patient performance status and cancer immunotherapy efficacy: a meta-analysis.
Bersanelli M; Brighenti M; Buti S; Barni S; Petrelli F
Med Oncol; 2018 Aug; 35(10):132. PubMed ID: 30128793
[TBL] [Abstract][Full Text] [Related]
16. Meta-analysis of survival prediction with Palliative Performance Scale.
Downing M; Lau F; Lesperance M; Karlson N; Shaw J; Kuziemsky C; Bernard S; Hanson L; Olajide L; Head B; Ritchie C; Harrold J; Casarett D
J Palliat Care; 2007; 23(4):245-52; discussion 252-4. PubMed ID: 18251442
[TBL] [Abstract][Full Text] [Related]
17. Systematic review of cancer presentations with a median survival of six months or less.
Salpeter SR; Malter DS; Luo EJ; Lin AY; Stuart B
J Palliat Med; 2012 Feb; 15(2):175-85. PubMed ID: 22023378
[TBL] [Abstract][Full Text] [Related]
18. The Spanish Adaptation of the Palliative Performance Scale (Version 2) Among Cancer Patients at the End of Life: Psychometric Properties.
Barallat E; Nabal M; Canal J; Trujillano J; Gea-Sánchez M; Larkin PJ; Downing MG
J Pain Symptom Manage; 2017 Oct; 54(4):570-577.e5. PubMed ID: 28712988
[TBL] [Abstract][Full Text] [Related]
19. Is performance status associated with symptom scores? A population-based longitudinal study among cancer outpatients.
Sutradhar R; Atzema C; Seow H; Earle C; Porter J; Howell D; Dudgeon D; Barbera L
J Palliat Care; 2014; 30(2):99-107. PubMed ID: 25058987
[TBL] [Abstract][Full Text] [Related]
20. Inter-rater reliability in performance status assessment between clinicians and patients: a systematic review and meta-analysis.
Chow R; Zimmermann C; Bruera E; Temel J; Im J; Lock M
BMJ Support Palliat Care; 2020 Jun; 10(2):129-135. PubMed ID: 31806655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
